» Articles » PMID: 17512507

Preconditioning and Postconditioning: the Essential Role of the Mitochondrial Permeability Transition Pore

Overview
Journal Cardiovasc Res
Date 2007 May 22
PMID 17512507
Citations 97
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The opening of the mitochondrial permeability transition pore (mPTP) at the time of myocardial reperfusion is a critical determinant of cell death. Emerging studies suggest that suppression of mPTP opening may underlie the cardioprotection elicited by both ischemic preconditioning (IPC) and postconditioning (IPost). To further evaluate the role of the mPTP in cardioprotection, we hypothesized that hearts deficient in cyclophilin-D (CYP-D-/-), a key component of the mPTP, will be resistant to cardioprotection conferred by ischemic and pharmacological preconditioning and postconditioning.

Methods And Results: Male/female wild type or CYP-D-/- mice were subjected to 30 min of ischemia and 120 min of reperfusion. In wild type mice subjected to in vivo myocardial ischemia-reperfusion injury, a significant reduction in myocardial infarct size was observed with the following treatments (n>/=6/group; P<0.05): (1) IPC (28+/-4% vs. 46.2+/-4% in control); (2) Diazoxide (5 mg/kg) pre-treatment (26.4+/-3% vs. 54+/-10% in vehicle control); (3) IPost-1 or IPost-2, three or six 10-s cycles of ischemia-reperfusion (27.2+/-3% and 32+/-4%, respectively vs. 46.2+/-4% in control); (4) Bradykinin (40 mug/kg) (28.3+/-1% vs. 48+/-4% in vehicle control); (5) cyclosporin-A (10 mg/kg) (32.3+/-3% vs. 48+/-4% in vehicle control) (6) sanglifehrin-A (25 mg/kg) (29.3+/-3% vs. 48+/-4% in vehicle control). Interestingly, however, no infarct-limiting effects were demonstrated in CYP-D-/- mice with the same treatment protocols: (27.9+/-5% in control vs. 31.2+/-7% with IPC, 30.2+/-5% with IPost-1, 24.7+/-8% with IPost-2; 30.1+/-4% in vehicle control vs. 26.4+/-7% with diazoxide; 24.6+/-4% in vehicle control vs. 24.9+/-5% with bradykinin, 26.8+/-7% with cyclosporin-A, 32.5+/-6% with sanglifehrin-A: n>/=6/group: P>0.05).

Conclusion: This study demonstrates that the mPTP plays a critical role in the cardioprotection elicited by ischemic and pharmacological preconditioning and postconditioning.

Citing Articles

BRG1 promotes liver cancer cell proliferation and metastasis by enhancing mitochondrial function and ATP5A1 synthesis through TOMM40.

Hui Y, Leng J, Jin D, Wang G, Liu K, Bu Y Cancer Biol Ther. 2024; 25(1):2375440.

PMID: 38978225 PMC: 11236295. DOI: 10.1080/15384047.2024.2375440.


A Mitochondrial Basis for Heart Failure Progression.

Watson W, Arvidsson P, Miller J, Lewis A, Rider O Cardiovasc Drugs Ther. 2024; 38(6):1161-1171.

PMID: 38878138 PMC: 11680631. DOI: 10.1007/s10557-024-07582-0.


Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardioprotection.

Heusch G, Andreadou I, Bell R, Bertero E, Botker H, Davidson S Redox Biol. 2023; 67:102894.

PMID: 37839355 PMC: 10590874. DOI: 10.1016/j.redox.2023.102894.


The RISK pathway leading to mitochondria and cardioprotection: how everything started.

Yellon D, Beikoghli Kalkhoran S, Davidson S Basic Res Cardiol. 2023; 118(1):22.

PMID: 37233787 PMC: 10220132. DOI: 10.1007/s00395-023-00992-5.


Mitochondria-associated endoplasmic reticulum membranes (MAMs): Possible therapeutic targets in heart failure.

Zhang Y, Yao J, Zhang M, Wang Y, Shi X Front Cardiovasc Med. 2023; 10:1083935.

PMID: 36776252 PMC: 9909017. DOI: 10.3389/fcvm.2023.1083935.


References
1.
Zhao Z, Corvera J, Halkos M, Kerendi F, Wang N, Guyton R . Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003; 285(2):H579-88. DOI: 10.1152/ajpheart.01064.2002. View

2.
Hausenloy D, Duchen M, Yellon D . Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovasc Res. 2003; 60(3):617-25. DOI: 10.1016/j.cardiores.2003.09.025. View

3.
Kokoszka J, Waymire K, Levy S, Sligh J, Cai J, Jones D . The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature. 2004; 427(6973):461-5. PMC: 3049806. DOI: 10.1038/nature02229. View

4.
Hausenloy D, Wynne A, Duchen M, Yellon D . Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection. Circulation. 2004; 109(14):1714-7. DOI: 10.1161/01.CIR.0000126294.81407.7D. View

5.
Juhaszova M, Zorov D, Kim S, Pepe S, Fu Q, Fishbein K . Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest. 2004; 113(11):1535-49. PMC: 419483. DOI: 10.1172/JCI19906. View